ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,037.47
-0.03%
Dow Jones
44,775.06
0.14%
US Dollar vs MXN
20.42087
-0.47%
Brent Oil
76.32
0.53%
Bitcoin
105,795.11
1.98%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Vapotherm Inc (VAPO)

  7. Vapotherm Inc (VAPO) Noticias

VAPO

Vapotherm (VAPO)

Vapotherm Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:VAPO
FechaHoraFuenteTítuloSímboloCompañía
24/09/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:VAPOVapotherm Inc
15/08/202408:06Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:VAPOVapotherm Inc
15/08/202407:32Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNYSE:VAPOVapotherm Inc
12/08/202416:15PR Newswire (US)Vapotherm Reports Second Quarter 2024 Financial ResultsNYSE:VAPOVapotherm Inc
30/07/202415:04Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNYSE:VAPOVapotherm Inc
18/07/202418:24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:VAPOVapotherm Inc
08/07/202405:55Edgar (US Regulatory)Form SC 13E3 - Going private transaction by certain issuersNYSE:VAPOVapotherm Inc
08/07/202405:06Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNYSE:VAPOVapotherm Inc
26/06/202415:16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:VAPOVapotherm Inc
29/04/202415:22Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NYSE:VAPOVapotherm Inc
01/04/202415:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:VAPOVapotherm Inc
27/02/202416:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:VAPOVapotherm Inc
15/12/202306:00GlobeNewswire Inc.OTC Markets Group Welcomes Vapotherm, Inc. to OTCQXNYSE:VAPOVapotherm Inc
14/12/202317:27PR Newswire (US)Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQXNYSE:VAPOVapotherm Inc
11/12/202305:45PR Newswire (US)Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQXNYSE:VAPOVapotherm Inc
28/11/202315:54PR Newswire (US)Vapotherm Educates over 8,000 Clinicians in Respiratory Care MonthNYSE:VAPOVapotherm Inc
08/11/202315:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:VAPOVapotherm Inc
08/11/202315:10PR Newswire (US)Vapotherm Reports Third Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
03/11/202309:53Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:VAPOVapotherm Inc
01/11/202305:45PR Newswire (US)Vapotherm To Report Third Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
04/10/202315:11Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:VAPOVapotherm Inc
04/10/202305:45Business WireComputational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulasNYSE:VAPOVapotherm Inc
25/09/202305:45Business WirePilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in childrenNYSE:VAPOVapotherm Inc
20/09/202305:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:VAPOVapotherm Inc
08/08/202315:10Business WireVapotherm Reports Second Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
25/07/202315:30Business WireVapotherm To Report Second Quarter 2023 Financial ResultsNYSE:VAPOVapotherm Inc
21/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NYSE:VAPOVapotherm Inc
24/05/202315:44Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:VAPOVapotherm Inc
05/05/202315:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:VAPOVapotherm Inc
05/05/202305:07Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:VAPOVapotherm Inc
 Showing the most relevant articles for your search:NYSE:VAPO

Su Consulta Reciente

BIT
UC92TG
Unicredit Bank
BIT
UC5QY9
Unicredit Bank
BIT
S24537
SG ISSUER
BIT
UC8QNS
Unicredit Bank
BIT
S24536
SG ISSUER
BIT
ESPY
L&G Cyber Security Innov...
BIT
S28168
Societe Generale Effekten
BIT
S25011
SG ISSUER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios